Increased risk of urinary tract infection and pyelonephritis under concomitant use of sodium-dependent glucose cotransporter 2 inhibitors with antidiabetic, antidyslipidemic, and antihypertensive drugs: An observational study.
Fundam Clin Pharmacol
; 36(6): 1106-1114, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-35484899
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyelonephritis
/
Urinary Tract Infections
/
Diabetes Mellitus, Type 2
/
Dipeptidyl-Peptidase IV Inhibitors
/
Sodium-Glucose Transporter 2 Inhibitors
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Fundam Clin Pharmacol
Journal subject:
FARMACOLOGIA
Year:
2022
Type:
Article
Affiliation country:
Japan